Type 2 diabetes

S Chatterjee, K Khunti, MJ Davies - The lancet, 2017 - thelancet.com
Summary 415 million people live with diabetes worldwide, and an estimated 193 million
people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients …

Fear of hypoglycemia—An underestimated problem

A Przezak, W Bielka, P Molęda - Brain and behavior, 2022 - Wiley Online Library
Introduction Fear of hypoglycemia (FOH) is a phenomenon that affects people with diabetes
experiencing hypoglycemia. On the one hand, FOH is an adaptive mechanism that helps to …

[PDF][PDF] ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes.

MB Abraham, TW Jones, D Naranjo, B Karges… - Pediatric diabetes, 2018 - bnsde.org
• If unexplained hypoglycemia is frequent, evaluation for unrecognized celiac and Addison's
disease should be considered (E).• Currently available technologies like CGM, automated …

Effect of insulin degludec vs insulin glargine U100 on hypoglycemia in patients with type 1 diabetes: the SWITCH 1 randomized clinical trial

W Lane, TS Bailey, G Gerety, J Gumprecht… - Jama, 2017 - jamanetwork.com
Importance Hypoglycemia, common in patients with type 1 diabetes, is a major barrier to
achieving good glycemic control. Severe hypoglycemia can lead to coma or death. Objective …

Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes

T Haak, H Hanaire, R Ajjan, N Hermanns, JP Riveline… - Diabetes Therapy, 2017 - Springer
Introduction Published evaluations of sensor glucose monitoring use in insulin treated type 2
diabetes are limited. The aim of this study was to assess the impact of flash glucose-sensing …

Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of …

P Oskarsson, R Antuna, P Geelhoed-Duijvestijn… - Diabetologia, 2018 - Springer
Aims/hypothesis Evidence for the effectiveness of interstitial glucose monitoring in
individuals with type 1 diabetes using multiple daily injection (MDI) therapy is limited. In this …

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 …

T Danne, B Cariou, P Banks, M Brandle, H Brath… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE The objective of this study was to evaluate the efficacy and safety of the dual
sodium–glucose cotransporter 1 and 2 inhibitor sotagliflozin compared with placebo when …

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in E urope and the USA

D Mauricio, L Meneghini, J Seufert… - Diabetes, Obesity …, 2017 - Wiley Online Library
Aims To evaluate short‐and long‐term glycaemic control and hypoglycaemia incidence in
insulin‐naïve patients≥ 30 years of age with type 2 diabetes (T2DM) initiating basal insulin …

Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen

SR Heller, M Peyrot, SK Oates… - BMJ Open Diabetes …, 2020 - drc.bmj.com
There are many misconceptions about the prevalence and effects of hypoglycemia in people
with type 2 diabetes (T2D), including hypoglycemia does not occur or does not have …

Beyond HbA1c: comparing glycemic variability and glycemic indices in predicting hypoglycemia in type 1 and type 2 diabetes

S Rama Chandran, WL Tay, WK Lye… - Diabetes technology …, 2018 - liebertpub.com
Background: Hypoglycemia is the major impediment to therapy intensification in diabetes.
Although higher individualized HbA1c targets are perceived to reduce the risk of …